{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:49:55Z","timestamp":1785412195685,"version":"3.56.0"},"posted":{"date-parts":[[2026,3,23]]},"group-title":"Cell Biology","reference-count":68,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"award":["R01 CA232056"],"award-info":[{"award-number":["R01 CA232056"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R01 AA026914"],"award-info":[{"award-number":["R01 AA026914"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R01 DK141923"],"award-info":[{"award-number":["R01 DK141923"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,25]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  Primary mitochondrial diseases are clinically and genetically heterogeneous disorders, commonly caused by defects in the oxidative phosphorylation system. This heterogeneity presents major challenges for therapeutic development; however, a shared hallmark across these diseases is the accumulation of dysfunctional mitochondria. Enhancing mitochondrial turnover, by activating the selective degradation of dysfunctional mitochondria via mitophagy, concurrently with the activation of mitochondrial biogenesis, could represent a shared therapeutic strategy for mitochondrial diseases. Here, we describe a novel mitophagy inducer, CAP-1902. CAP-1902 is a new agonist of the MAS G-Protein Coupled Receptor (MasR). In fibroblasts from patients carrying a\n                  <jats:italic>BCS1L<\/jats:italic>\n                  mutation that impairs complex III (CIII) assembly, CAP-1902 increased mitochondrial turnover by promoting both mitophagy and biogenesis. Specifically, MasR activation triggered the AMPK\/ULK1\/FUNDC1 mitophagy pathway. Knockdown of FUNDC1 blocked mitophagy but not AMPK activation, confirming pathway specificity. Additionally, a decrease in the occurrence of depolarized mitochondria with treatment indicated the selective targeting of accumulated damaged mitochondria in the disease context. MasR activation by CAP-1902 also stimulated the nuclear translocation of PGC-1\u03b1, promoting increased expression of transcripts associated with mitochondrial biogenesis, respiratory chain components, and mitochondrial translation. Remarkably, CAP-1902 was ultimately able to restore key defects in CIII-deficient fibroblasts by rescuing bioenergetics and correcting both the aberrant lysosomal distribution and the elevated integrated stress response markers, which is consistent with a shift toward a healthier mitochondrial population. In summary, we describe the first potential GPCR-mediated treatment of mitochondrial diseases and demonstrate that MasR activation by CAP-1902 induces mitochondrial turnover and improves mitochondrial function.\n                <\/jats:p>","DOI":"10.64898\/2026.03.20.711686","type":"posted-content","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:35:18Z","timestamp":1774265718000},"source":"Crossref","is-referenced-by-count":0,"title":["Activation of the protective arm of renin-angiotensin system enhances mitochondrial turnover improving respiration and decreasing integrated stress response in a human Complex III deficiency model"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5657-2700","authenticated-orcid":false,"given":"Luc\u00eda","family":"Fern\u00e1ndez-del-R\u00edo","sequence":"first","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Mitochondria and Metabolism Core, University of California, Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9271-1891","authenticated-orcid":false,"given":"Andrea","family":"Eastes","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6217-3757","authenticated-orcid":false,"given":"David","family":"Rinc\u00f3n Fern\u00e1ndez Pacheco","sequence":"additional","affiliation":[{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikole","family":"Scillitani","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Mitochondria and Metabolism Core, University of California, Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Garza","sequence":"additional","affiliation":[{"name":"Mitochondria and Metabolism Core, University of California, Los Angeles, USA"},{"name":"Capacity Bio Inc., Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dugan","sequence":"additional","affiliation":[{"name":"Mitochondria and Metabolism Core, University of California, Los Angeles, USA"},{"name":"Capacity Bio Inc., Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-8799","authenticated-orcid":false,"given":"Matheus","family":"Pinto de Oliveira","sequence":"additional","affiliation":[{"name":"Capacity Bio Inc., Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5079-2927","authenticated-orcid":false,"given":"Pradnya","family":"Kadam","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Mitochondria and Metabolism Core, University of California, Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Gauhar","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Mitochondria and Metabolism Core, University of California, Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7555-5199","authenticated-orcid":false,"given":"Karel","family":"Erion","sequence":"additional","affiliation":[{"name":"Capacity Bio Inc., Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Rodgers","sequence":"additional","affiliation":[{"name":"Center for Innovation in Brain Science, University of Arizona, Tucson, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Gaffney","sequence":"additional","affiliation":[{"name":"Capacity Bio Inc., Los Angeles, USA"},{"name":"Center for Innovation in Brain Science, University of Arizona, Tucson, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Wang","sequence":"additional","affiliation":[{"name":"Capacity Bio Inc., Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5909-8570","authenticated-orcid":false,"given":"Marc","family":"Liesa","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Institut de Biologia Molecular de Barcelona, IBMB-CSIC, Barcelona, Spain"},{"name":"Ciberdem, Instituto de Salud Carlos III, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7933-860X","authenticated-orcid":false,"given":"Cristiane","family":"Beninc\u00e1","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Mitochondria and Metabolism Core, University of California, Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-3431","authenticated-orcid":false,"given":"Orian","family":"Shaul Shirihai","sequence":"additional","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, USA"},{"name":"Mitochondria and Metabolism Core, University of California, Los Angeles, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"issue":"1","key":"2026032712551642000_2026.03.20.711686v2.1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","article-title":"Mitochondrial diseases: from molecular mechanisms to therapeutic advances","volume":"10","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"2026032712551642000_2026.03.20.711686v2.2","doi-asserted-by":"crossref","unstructured":"Civiletto, G. , et al., Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis. EMBO Mol Med, 2018. 10(11).","DOI":"10.15252\/emmm.201708799"},{"key":"2026032712551642000_2026.03.20.711686v2.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.01.039"},{"key":"2026032712551642000_2026.03.20.711686v2.4","doi-asserted-by":"crossref","unstructured":"Zheng, X. , et al., Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration. Elife, 2016. 5.","DOI":"10.7554\/eLife.13378"},{"key":"2026032712551642000_2026.03.20.711686v2.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.1244360"},{"key":"2026032712551642000_2026.03.20.711686v2.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.12.017"},{"key":"2026032712551642000_2026.03.20.711686v2.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2008.12.3959"},{"key":"2026032712551642000_2026.03.20.711686v2.8","doi-asserted-by":"crossref","unstructured":"Acevedo, A. , et al., The BCKDK inhibitor BT2 is a chemical uncoupler that lowers mitochondrial ROS production and de novo lipogenesis. Journal of Biological Chemistry, 2024. 300(3).","DOI":"10.1016\/j.jbc.2024.105702"},{"key":"2026032712551642000_2026.03.20.711686v2.9","doi-asserted-by":"crossref","first-page":"732690","DOI":"10.3389\/fimmu.2021.732690","article-title":"Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19","volume":"12","year":"2021","journal-title":"Front Immunol"},{"key":"2026032712551642000_2026.03.20.711686v2.10","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-04138-6"},{"issue":"13","key":"2026032712551642000_2026.03.20.711686v2.11","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1080\/15384101.2023.2228089","article-title":"Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases","volume":"22","year":"2023","journal-title":"Cell Cycle"},{"issue":"1","key":"2026032712551642000_2026.03.20.711686v2.12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41392-023-01430-7","article-title":"Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions","volume":"8","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"2026032712551642000_2026.03.20.711686v2.13","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1152\/japplphysiol.00898.2018","article-title":"Angiotensin II suppresses autophagy and disrupts ultrastructural morphology and function of mitochondria in mouse skeletal muscle","volume":"126","year":"2019","journal-title":"J Appl Physiol (1985)"},{"issue":"6","key":"2026032712551642000_2026.03.20.711686v2.14","doi-asserted-by":"crossref","first-page":"H1426","DOI":"10.1152\/ajpheart.00772.2018","article-title":"Mitochondrial angiotensin receptors and cardioprotective pathways","volume":"316","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"2026032712551642000_2026.03.20.711686v2.15","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1007\/s12035-017-0805-y","article-title":"Paracrine and Intracrine Angiotensin 1-7\/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans","volume":"55","year":"2018","journal-title":"Mol Neurobiol"},{"key":"2026032712551642000_2026.03.20.711686v2.16","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(90)90027-W"},{"key":"2026032712551642000_2026.03.20.711686v2.17","doi-asserted-by":"crossref","unstructured":"Killackey, S.A. , D.J. Philpott , and S.E. Girardin , Mitophagy pathways in health and disease. J Cell Biol, 2020. 219(11).","DOI":"10.1083\/jcb.202004029"},{"key":"2026032712551642000_2026.03.20.711686v2.18","doi-asserted-by":"crossref","unstructured":"Abu Shelbayeh, O. , et al., PGC-1alpha Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. Antioxidants (Basel), 2023. 12(5).","DOI":"10.3390\/antiox12051075"},{"key":"2026032712551642000_2026.03.20.711686v2.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015394"},{"key":"2026032712551642000_2026.03.20.711686v2.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2015.05.020"},{"key":"2026032712551642000_2026.03.20.711686v2.21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2017.04.005","article-title":"Mitophagy and age-related pathologies: Development of new therapeutics by targeting mitochondrial turnover","volume":"178","year":"2017","journal-title":"Pharmacol Ther"},{"key":"2026032712551642000_2026.03.20.711686v2.22","doi-asserted-by":"crossref","unstructured":"Liu, J. , et al., AMPK: a balancer of the renin-angiotensin system. Biosci Rep, 2019. 39(9).","DOI":"10.1042\/BSR20181994"},{"key":"2026032712551642000_2026.03.20.711686v2.23","doi-asserted-by":"crossref","unstructured":"Nager, M. , et al., Mitophagy is induced in human engineered heart tissue after simulated ischemia and reperfusion. J Cell Sci, 2025. 138(9).","DOI":"10.1242\/jcs.263408"},{"issue":"1","key":"2026032712551642000_2026.03.20.711686v2.24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41467-024-45044-1","article-title":"Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS\/STING inflammation during aging","volume":"15","year":"2024","journal-title":"Nat Commun"},{"key":"2026032712551642000_2026.03.20.711686v2.25","doi-asserted-by":"publisher","DOI":"10.4161\/auto.19496"},{"key":"2026032712551642000_2026.03.20.711686v2.26","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2010.3779"},{"key":"2026032712551642000_2026.03.20.711686v2.27","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.11.3738-3749.2001"},{"key":"2026032712551642000_2026.03.20.711686v2.28","doi-asserted-by":"crossref","first-page":"170329","DOI":"10.1016\/j.peptides.2020.170329","article-title":"Angiotensin-(1-7) receptor Mas antagonist (A779) influenced gliosis and reduced synaptic density in the spinal cord after peripheral axotomy","volume":"129","year":"2020","journal-title":"Peptides"},{"key":"2026032712551642000_2026.03.20.711686v2.29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1196371"},{"key":"2026032712551642000_2026.03.20.711686v2.30","doi-asserted-by":"publisher","DOI":"10.1002\/embr.201438501"},{"issue":"1","key":"2026032712551642000_2026.03.20.711686v2.31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13238-016-0328-8","article-title":"Structural insights into the recognition of phosphorylated FUNDC1 by LC3B in mitophagy","volume":"8","year":"2017","journal-title":"Protein Cell"},{"key":"2026032712551642000_2026.03.20.711686v2.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.05.009"},{"key":"2026032712551642000_2026.03.20.711686v2.33","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2204"},{"key":"2026032712551642000_2026.03.20.711686v2.34","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mie.2016.09.052"},{"key":"2026032712551642000_2026.03.20.711686v2.35","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201702058"},{"key":"2026032712551642000_2026.03.20.711686v2.36","doi-asserted-by":"crossref","unstructured":"Kaspar, S. , et al., Adaptation to mitochondrial stress requires CHOP-directed tuning of ISR. Sci Adv, 2021. 7(22).","DOI":"10.1126\/sciadv.abf0971"},{"key":"2026032712551642000_2026.03.20.711686v2.37","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170616101741"},{"key":"2026032712551642000_2026.03.20.711686v2.38","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.86"},{"key":"2026032712551642000_2026.03.20.711686v2.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2015.08.027"},{"key":"2026032712551642000_2026.03.20.711686v2.40","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4132"},{"key":"2026032712551642000_2026.03.20.711686v2.41","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx341"},{"key":"2026032712551642000_2026.03.20.711686v2.42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ebiom.2019.03.025","article-title":"Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease","volume":"42","year":"2019","journal-title":"EBioMedicine"},{"key":"2026032712551642000_2026.03.20.711686v2.43","doi-asserted-by":"crossref","first-page":"175623","DOI":"10.1016\/j.ejphar.2023.175623","article-title":"ACE2\/ANG-(1-7)\/Mas receptor axis activation prevents inflammation and improves cognitive functions in streptozotocin induced rat model of Alzheimer\u2019s disease-like phenotypes","volume":"946","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"2026032712551642000_2026.03.20.711686v2.44","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13742"},{"issue":"2","key":"2026032712551642000_2026.03.20.711686v2.45","doi-asserted-by":"crossref","first-page":"e13750","DOI":"10.1002\/jcsm.13750","article-title":"BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial","volume":"16","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026032712551642000_2026.03.20.711686v2.46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.001469"},{"key":"2026032712551642000_2026.03.20.711686v2.47","doi-asserted-by":"crossref","first-page":"1344075","DOI":"10.3389\/fphar.2024.1344075","article-title":"Mitophagy regulates mitochondrial number following pharmacological induction of mitochondrial biogenesis in renal proximal tubule cells","volume":"15","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026032712551642000_2026.03.20.711686v2.48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026883"},{"key":"2026032712551642000_2026.03.20.711686v2.49","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2016.1101068"},{"issue":"22","key":"2026032712551642000_2026.03.20.711686v2.50","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1016\/j.molcel.2024.10.025","article-title":"Opposing roles for AMPK in regulating distinct mitophagy pathways","volume":"84","year":"2024","journal-title":"Mol Cell"},{"issue":"2","key":"2026032712551642000_2026.03.20.711686v2.51","first-page":"e1","article-title":"Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension","volume":"136","year":"2025","journal-title":"Circ Res"},{"key":"2026032712551642000_2026.03.20.711686v2.52","doi-asserted-by":"crossref","first-page":"114891","DOI":"10.1016\/j.bcp.2021.114891","article-title":"The role of FUNDC1 in mitophagy, mitochondrial dynamics and human diseases","volume":"197","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"2026032712551642000_2026.03.20.711686v2.53","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2016.1151580"},{"key":"2026032712551642000_2026.03.20.711686v2.54","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050629"},{"key":"2026032712551642000_2026.03.20.711686v2.55","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e328328d0a4"},{"key":"2026032712551642000_2026.03.20.711686v2.56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705070104"},{"key":"2026032712551642000_2026.03.20.711686v2.57","doi-asserted-by":"crossref","first-page":"177305","DOI":"10.1016\/j.ejphar.2025.177305","article-title":"The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy\/ACE2\/SIRT1\/FOXO1-Mediated Microglia Polarization","volume":"991","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"2026032712551642000_2026.03.20.711686v2.58","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201603039"},{"key":"2026032712551642000_2026.03.20.711686v2.59","doi-asserted-by":"crossref","unstructured":"Frost, L.S. , et al., Chapter Three - The Use of DQ-BSA to Monitor the Turnover of Autophagy-Associated Cargo, in Methods in Enzymology, L. Galluzzi , J.M. Bravo-San Pedro , and G. Kroemer , Editors. 2017, Academic Press. p. 43\u201354.","DOI":"10.1016\/bs.mie.2016.09.052"},{"key":"2026032712551642000_2026.03.20.711686v2.60","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp616"},{"key":"2026032712551642000_2026.03.20.711686v2.61","unstructured":"Korotkevich, G. , et al., Fast gene set enrichment analysis. bioRxiv, 2021: p. 060012."},{"key":"2026032712551642000_2026.03.20.711686v2.62","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAD1025"},{"key":"2026032712551642000_2026.03.20.711686v2.63","doi-asserted-by":"publisher","DOI":"10.1039\/C5MB00663E"},{"key":"2026032712551642000_2026.03.20.711686v2.64","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr260"},{"key":"2026032712551642000_2026.03.20.711686v2.65","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801415-8.00016-3"},{"key":"2026032712551642000_2026.03.20.711686v2.66","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202256380"},{"key":"2026032712551642000_2026.03.20.711686v2.67","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(88)91308-4"},{"key":"2026032712551642000_2026.03.20.711686v2.68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.232591499"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.03.20.711686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T19:55:29Z","timestamp":1774641329000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.03.20.711686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":68,"URL":"https:\/\/doi.org\/10.64898\/2026.03.20.711686","relation":{},"subject":[],"published":{"date-parts":[[2026,3,23]]},"subtype":"preprint"}}